Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa.

Anja Maag Nienke van ReinTim J SchuijtWil F KopatzDanielle KruijswijkStella ThomassenTilman M HackengRodney M CamireTom van der PollJoost C M MeijersMettine H A BosCornelis van 't Veer

Published in: Journal of thrombosis and haemostasis : JTH (2021)

A greater dependence on FXa-mediated activation of FV of TG is associated with increased risk of major bleeding during VKA therapy.

Keyphrases

atrial fibrillation
venous thromboembolism
stem cells
bone marrow
cell therapy
smoking cessation